Mineralys Therapeutics, Inc. Common Stock Long-term Investment Intensity
Mineralys Therapeutics, Inc. Common Stock long-term investment intensity. Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Long-term Investment Intensity of 1.0% as of December 2023. Long-term investments of $2.48 Million represent 1.0% of total assets of $251.64 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read MLYS total liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Mineralys Therapeutics, Inc. Common Stock (2023–2023)
Long-term investment intensity of Mineralys Therapeutics, Inc. Common Stock from 2023 to 2023. This chart shows how Mineralys Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2023 to 2023. As of December 2023, the intensity stands at 1.0%, reflecting long-term investments of $2.48 Million against total assets of $251.64 Million USD.
Mineralys Therapeutics, Inc. Common Stock Long-term Investment Intensity by Year (2023–2023)
Mineralys Therapeutics, Inc. Common Stock long-term investment intensity by year from 2023 to 2023. The table below presents the year-by-year Long-term Investment Intensity for Mineralys Therapeutics, Inc. Common Stock from 2023 to 2023, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Mineralys Therapeutics, Inc. Common Stoc asset portfolio.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 1.0% | $2.48 Million | $251.64 Million | — |